Cargando…

Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study

BACKGROUND: A multicenter observational study was conducted in Italy to assess the safety of micafungin in the daily clinical practice for the treatment of proven and suspected invasive candidiasis (IC), as well as to describe rates of clinical response to micafungin treatment. METHODS: From October...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viscoli, Claudio, Bassetti, Matteo, Castagnola, Elio, Cesaro, Simone, Menichetti, Francesco, Ratto, Sandra, Tascini, Carlo, Giacobbe, Daniele Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297391/ https://www.ncbi.nlm.nih.gov/pubmed/25551699 http://dx.doi.org/10.1186/s12879-014-0725-7

Ejemplares similares

Invasive Candidiasis in Non-Hematological Patients
por: Mikulska, Malgorzata, et al.
Publicado: (2011)

Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis
por: Grant, Victoria C., et al.
Publicado: (2022)

Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
por: Bassetti, Matteo, et al.
Publicado: (2010)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia
por: Kuse, ER, et al.
Publicado: (2008)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
por: Leroy, Olivier, et al.
Publicado: (2016)

Prophylaxis and Empirical Therapy of Infection in Cancer Patients
por: Castagnola, Elio, et al.
Publicado: (2015)

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
por: van der Geest, Patrick J., et al.
Publicado: (2016)

Exposure–Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials
por: Kovanda, Laura L., et al.
Publicado: (2018)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
por: Benjamin, Daniel K., et al.
Publicado: (2018)

Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: A non-comparative, multicenter, phase IV, open-label study
por: Ji, Yu, et al.
Publicado: (2017)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
por: Wilke, MH
Publicado: (2011)

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
por: Kohno, S., et al.
Publicado: (2012)

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis
por: Ashizawa, Nobuyuki, et al.
Publicado: (2019)

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients
por: Cesaro, Simone, et al.
Publicado: (2007)

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
por: Bassetti, Matteo, et al.
Publicado: (2020)

Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19
por: Peghin, Maddalena, et al.
Publicado: (2022)

Differences between intraabdominal candidiasis in regular wards versus intensive care unit
por: Lagunes, L, et al.
Publicado: (2015)

Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
por: Shirazi, Fazal, et al.
Publicado: (2015)

Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials
por: Nucci, M, et al.
Publicado: (2009)

Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin – case study and brief literature review
por: Barańska, Marta, et al.
Publicado: (2017)

Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam
por: Bassetti, Matteo, et al.
Publicado: (2020)

Fidaxomicin for the Treatment of Clostridioides difficile Infection in Adult Patients: An Update on Results from Randomized Controlled Trials
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child–Pugh B or C Liver Disease: A Case–Control Retrospective Study
por: Vena, Antonio, et al.
Publicado: (2020)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies
por: De Rose, Domenico Umberto, et al.
Publicado: (2023)

Beta Lactams Plus Daptomycin Combination Therapy for Infective Endocarditis: An Italian National Survey (BADAS)
por: Corcione, Silvia, et al.
Publicado: (2022)

Review of the pharmacology and clinical studies of micafungin
por: Bormann, Alison M, et al.
Publicado: (2009)

Cardiac Safety of High-dose Micafungin
por: Stover, Kayla R., et al.
Publicado: (2017)

Pharmacokinetics of Micafungin in Critically Ill Patients
por: Gastine, Silke, et al.
Publicado: (2019)

Effectiveness and Tolerability of Micafungin in Chinese Patients with Invasive Fungal Infections: A Retrospective, Multicenter Study
por: Zheng, Xiaoyun, et al.
Publicado: (2018)

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
por: Dupont, Bertrand F, et al.
Publicado: (2009)

The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia
por: Mikulska, Małgorzata, et al.
Publicado: (2010)

Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts
por: Corte, Laura, et al.
Publicado: (2016)

415. Epidemiological Evaluation of Antibiotic Resistance and Subsequent Effect on Healthcare Resource Utilization among Subjects with Pseudomonas aeruginosa Infections in Italy
por: Bassetti, Matteo, et al.
Publicado: (2022)

Demographic and outcome differences in ICU patients with proven invasive candidiasis, possible invasive candidiasis and probable candida colonization: analysis of the EPIC II study population
por: Kett, D, et al.
Publicado: (2011)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4q3r6j27dgs09g5cqa7741sjv4